Latest IR information
IR News
- 2026.10.14
- UK MHRA Accepts Briefing Book for Face-to-Face Scientific Advice Meeting on Conditional Marketing Authorisation for Brincidofovir (BCV)
- 2026.10.08
- SymBio Announces Initiation of Compassionate Use Program for Brincidofovir
- 2026.10.06
- SymBio Pharmaceuticals Commenced Discussions with the UK MHRA Toward Obtaining Conditional Marketing Authorisation for Brincidofovir (BCV)
- 2026.10.01
- Notice Regarding the Monthly Exercise Status of the 70th and 71st Stock Acquisition Rights (with Exercise Price Adjustment Clause) Issued through Third-Party Allotment
- 2026.09.24
- SymBio Pharmaceuticals Announces Exclusive Global License Agreement with the U.S. Department of Health and Human Services for Treatment of Multiple Sclerosis with BCV